(Q48157021)

English

Isotretinoin updates

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/24099068

Isotretinoin updates (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/24099068

author name string

Shelbi C Jim On

1

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/24099068

Joshua Zeichner

2

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/24099068

publication date

1 September 2013

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/24099068

Dermatologic Therapy

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/24099068

26

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/24099068

5

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/24099068

377-389

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/24099068

Descriptive epidemiology of acne vulgaris in the community

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Multimodal treatment of acne, acne scars and pigmentation

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Acne in infancy and acne genetics

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Diet and acne: a review of the evidence

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

The effectiveness of acne treatment: an assessment by patients of the outcome of therapy.

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Inflammatory events are involved in acne lesion initiation

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

The complete genome sequence of Propionibacterium acnes, a commensal of human skin

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Insights in the pathogenic potential of Propionibacterium acnes from its complete genome

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Pharmacokinetics of isotretinoin following a single oral dose.

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

The use of isotretinoin in acne

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

13-cis retinoic acid exerts its specific activity on human sebocytes through selective intracellular isomerization to all-trans retinoic acid and binding to retinoid acid receptors

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

RAR and RXR modulation in cancer and metabolic disease

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Current use and future potential role of retinoids in dermatology

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

13-cis Retinoic acid induces apoptosis and cell cycle arrest in human SEB-1 sebocytes

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Does oral isotretinoin prevent Propionibacterium acnes resistance?

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Retinoic acid amplifies the host immune response to LPS through increased T lymphocytes number and LPS binding protein expression

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Systemic isotretinoin therapy normalizes exaggerated TLR-2-mediated innate immune responses in acne patients

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Prolonged Remissions of Cystic and Conglobate Acne with 13-cis-Retinoic Acid

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Isotretinoin: dose, duration and relapse. What does 30 years of usage tell us?

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Isotretinoin--unapproved indications/uses and dosage: a physician's reference

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Chemoprevention of Skin Cancer in Xeroderma Pigmentosum

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% for the once-daily treatment of moderate to severe acne vulgaris: assessment of efficacy and safety in 2813 patients

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Profile of acne patients in the Philippines requiring a second course of oral isotretinoin

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Prospective study of risk factors of relapse after treatment of acne with oral isotretinoin

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Isotretinoin therapy in acne vulgaris: a 10-year retrospective study in Singapore

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Isotretinoin for the treatment of acne vulgaris: which factors may predict the need for more than one course?

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Isotretinoin therapy and the incidence of acne relapse: a nested case-control study

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Isotretinoin for acne vulgaris--10 years later: a safe and successful treatment

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Effectiveness of conventional, low-dose and intermittent oral isotretinoin in the treatment of acne: a randomized, controlled comparative study.

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

High albumin levels restrict the kinetics of 13-cis retinoic acid uptake and intracellular isomerization to all-trans retinoic acid and inhibit its anti-proliferative effect on SZ95 sebocytes

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Food increases the bioavailability of isotretinoin.

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Management of acne: a report from a Global Alliance to Improve Outcomes in Acne.

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

A population-based analysis of laboratory abnormalities during isotretinoin therapy for acne vulgaris.

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Low-dose isotretinoin in the treatment of acne vulgaris

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Acne vulgaris in the elderly: the response to low-dose isotretinoin

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

A randomized trial of the efficacy of a new micronized formulation versus a standard formulation of isotretinoin in patients with severe recalcitrant nodular acne

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Low dose isotretinoin combined with tretinoin is effective to correct abnormalities of acne

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Efficacy of fixed low-dose isotretinoin (20 mg, alternate days) with topical clindamycin gel in moderately severe acne vulgaris

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Roaccutane treatment guidelines: results of an international survey

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

High-dose isotretinoin in acne vulgaris: improved treatment outcomes and quality of life

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Treatment of acne with intermittent and conventional isotretinoin: a randomized, controlled multicenter study.

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Oral isotretinoin. How can we treat difficult acne patients?

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Retinoic acid embryopathy

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Sensitivity, specificity, and positive predictive value of multiple malformations in isotretinoin embryopathy surveillance

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Neurobehavioral teratology of isotretinoin

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

A Pregnancy-Prevention Program in Women of Childbearing Age Receiving Isotretinoin

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

iPLEDGE allegiance to the pill: evaluation of year 1 of a birth defect prevention and monitoring system

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Systemic retinoid therapy

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

High risk for hyperlipidemia and the metabolic syndrome after an episode of hypertriglyceridemia during 13-cis retinoic acid therapy for acne: a pharmacogenetic study

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

A causal association between isotretinoin and inflammatory bowel disease has yet to be established.

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Isotretinoin-Induced Inflammatory Bowel Disease in an Adolescent

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Isotretinoin is not associated with inflammatory bowel disease: a population-based case-control study.

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Isotretinoin use and the risk of inflammatory bowel disease: a population-based cohort study.

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Isotretinoin and risk for inflammatory bowel disease: a nested case-control study and meta-analysis of published and unpublished data

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Isotretinoin use and the risk of inflammatory bowel disease: a case-control study

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Acne treatment and inflammatory bowel disease: what is the evidence?

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Depression--a side effect of 13-cis-retinoic acid therapy

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Isotretinoin use and subsequent depression and suicide: presenting the evidence

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

13-cis-retinoic acid suppresses hippocampal cell division and hippocampal-dependent learning in mice

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Advice on the safe introduction and continued use of isotretinoin in acne in the U.K. 2010.

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Isotretinoin and psychopathology: a review

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Impaired locomotion and dopamine signaling in retinoid receptor mutant mice

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Regulation of dopaminergic pathways by retinoids: activation of the D2 receptor promoter by members of the retinoic acid receptor-retinoid X receptor family.

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Functional brain imaging alterations in acne patients treated with isotretinoin

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Oral treatment with ACCUTANE does not increase measures of anhedonia or depression in rats

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Chronic oral treatment with 13-cis-retinoic acid (isotretinoin) or all-trans-retinoic acid does not alter depression-like behaviors in rats

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Suicide, depression, and isotretinoin: is there a causal link?

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

An analysis of reports of depression and suicide in patients treated with isotretinoin

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Adverse effects of isotretinoin: A retrospective review of 1743 patients started on isotretinoin

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Incidence of depression related to isotretinoin treatment in 100 acne vulgaris patients

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Comparison of depression, anxiety and life quality in acne vulgaris patients who were treated with either isotretinoin or topical agents

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Association of suicide attempts with acne and treatment with isotretinoin: retrospective Swedish cohort study

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Effects of isotretinoin on obsessive compulsive symptoms, depression, and anxiety in patients with acne vulgaris

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Early skeletal hyperostoses secondary to 13-cis-retinoic acid.

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Isotretinoin therapy is associated with early skeletal radiographic changes.

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Effect of a single course of isotretinoin therapy on bone mineral density in adolescent patients with severe, recalcitrant, nodular acne

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Effects of isotretinoin on bone mineralization during routine therapy with isotretinoin for acne vulgaris

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

What is the cumulative effect of long-term, low-dose isotretinoin on the development of DISH?

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Isotretinoin therapy for acne vulgaris: a re-evaluation of the need for measurements of plasma lipids and liver function tests.

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Analysis of laboratory data in acne patients treated with isotretinoin: is there really a need to perform routine laboratory tests?

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Creatine phosphokinase values during isotretinoin treatment for acne

1 reference

https://api.crossref.org/works/10.1111%2FDTH.12084

21 January 2018

Identifiers

10.1111/DTH.12084

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/24099068

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/24099068

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48157021&oldid=2187983933"